Alicia Langeway is a seasoned life sciences professional and commercial leader with more than two decades of experience spanning biotechnology, pharmaceuticals, and advanced scientific instrumentation. Throughout her career, she has combined deep technical knowledge with strategic sales leadership to support the growth of organizations at every stage—from emerging biotech innovators to established multinational companies. Known for her ability to bridge the gap between complex scientific technologies and the organizations that rely on them, Alicia has built a reputation as a trusted advisor to research institutions, pharmaceutical companies, and biotechnology leaders across North America.
Previously serving as Sales Director for Eastern North America at RareCyte, Inc., Alicia leads commercial efforts supporting pharmaceutical, academic, research, and biotechnology organizations throughout the United States and Canada. In this role, she oversees the sales of advanced instrumentation, reagents, and consumables that power cutting-edge research in spatial biology and oncology. Her work includes supporting customers utilizing the Orion multiplex imaging system for spatial biology and the CyteFinder platform for liquid biopsy imaging and cell picking. Through her leadership, Alicia helps accelerate the adoption of innovative technologies that enable researchers and clinicians to better understand disease at the cellular level.
Alicia’s career has been shaped by a consistent commitment to enabling scientific progress. She has developed extensive expertise in capital equipment sales, spatial biology technologies, oncology research tools, and advanced cellular analysis platforms such as flow cytometry and cell sorting. Her ability to translate complex technical concepts into strategic business opportunities has made her a valuable partner to organizations seeking to bring novel technologies to market and expand their scientific impact.
Prior to joining RareCyte, Alicia served as a Technical Sales Specialist at NanoCellect Biomedical, where she supported pharmaceutical, academic, and biotechnology customers across New England, New York, and Eastern Canada. In this role, she led sales of the WOLF and WOLF G2 cell sorting platforms and associated consumables. Her performance earned her recognition as the company’s top representative in 2021, achieving 99 percent of her sales target and demonstrating her consistent ability to drive growth in highly specialized scientific markets.
Earlier in her career, Alicia was a Flow Cytometry Sales Specialist at Luminex Corporation, where she was responsible for both instrumentation and reagent revenue across a broad regional territory. Her strong performance resulted in achieving more than 127 percent of her sales target and earning the distinction of being the number one flow specialist in 2019. This role further strengthened her ability to build long-term relationships with scientific leaders and guide organizations in selecting technologies that advance their research and clinical goals.
Alicia also held multiple roles at MilliporeSigma, including Flow Cytometry Specialist and Biomarker and Cytometry Specialist. During her time there, she consistently exceeded sales targets and was recognized as a top performer within the organization. Her work focused on supporting customers using advanced instrumentation and reagents for biomarker research, flow cytometry, and molecular analysis. Through this experience, she gained valuable insight into the rapidly evolving needs of life sciences organizations and the technologies that support modern biomedical research.
Earlier in her professional journey, Alicia worked at Beckman Coulter as an Account Sales Consultant supporting clinical and research customers throughout the northeastern United States. Her responsibilities included managing both instrumentation and reagent sales while building strong relationships with laboratories and healthcare organizations. These experiences helped establish her expertise in scientific instrumentation and commercial strategy within highly technical markets.
Before transitioning into commercial leadership, Alicia built a strong scientific foundation through roles in research and technical support. She served as a Technical Support Scientist at EMD Millipore, where she provided advanced technical assistance to customers and internal teams while collaborating with research, manufacturing, and marketing groups. Earlier, she worked as a Research Associate at the Massachusetts Stem Cell Bank and as a Research Scientist at Microbiotix, Inc., contributing to stem cell research, molecular biology studies, and infectious disease research. These early experiences gave Alicia a firsthand understanding of laboratory science and the challenges researchers face in advancing scientific discovery.
Alicia’s academic background further reinforces her deep scientific expertise. She earned a Master of Science in Animal Biotechnology and Biomedical Science from the University of Massachusetts Amherst, where her research focused on reproductive physiology and molecular signaling. Her thesis explored the role of novel CRISP proteins in mammalian sperm physiology, reflecting her early interest in cellular biology and complex biological systems. She also holds a Bachelor of Science in Animal Science from the same institution.
In addition to her commercial leadership and scientific expertise, Alicia has contributed to the broader scientific community through academic publications and collaborative research efforts. Her work has been published in respected scientific journals and texts, including contributions to Human Stem Cell Technology and Biology: A Research Guide and Laboratory Manual. These publications reflect her early research contributions in stem cell biology, molecular signaling pathways, and reproductive physiology.
Beyond her professional achievements, Alicia is motivated by a strong desire to support the continued advancement of science-driven organizations. She believes that serving on a board provides an opportunity to share her unique perspective gained from working across organizations of different sizes and stages of growth. Her experience with both emerging biotech companies and global industry leaders gives her valuable insight into how organizations scale, innovate, and navigate complex scientific markets.
Alicia has also demonstrated a commitment to community engagement through her service on the board of the Enfield Food Shelf in Connecticut. Through this role, she has contributed to efforts supporting community resources and food access, reinforcing her belief that leadership extends beyond professional success and includes meaningful service to others.
Throughout her career, Alicia Langeway has demonstrated a powerful combination of scientific expertise, commercial leadership, and relationship-driven strategy. She is passionate about helping organizations translate innovative science into real-world impact and remains committed to advancing technologies that improve research, healthcare, and patient outcomes. Her career reflects not only a deep understanding of life sciences innovation but also a dedication to building partnerships that help organizations grow, evolve, and contribute to the future of biotechnology.
Character:
Alicia Langeway demonstrates integrity and professionalism in every aspect of her career, building trust with colleagues, customers, and industry partners through transparency and reliability. She approaches leadership with humility and a genuine desire to help others succeed, fostering collaborative environments where innovation can thrive. Her commitment to community service and her support of scientific advancement reflect a values-driven approach to leadership that prioritizes both impact and responsibility.
Knowledge:
She possesses deep technical expertise in life sciences, biotechnology instrumentation, and cellular analysis technologies developed through both laboratory research and commercial leadership. Her academic background and industry experience allow her to understand complex scientific systems while identifying practical business opportunities. This combination of scientific literacy and strategic insight enables her to guide organizations in adopting technologies that accelerate research and innovation.
Strategic:
Alicia brings a strategic perspective shaped by years of working with organizations ranging from early-stage biotech startups to global life sciences companies. She understands how different organizational structures approach growth, commercialization, and technology adoption, allowing her to provide valuable strategic guidance. Her ability to identify opportunities for expansion, build strong partnerships, and drive market adoption has consistently produced measurable results throughout her career.
Communication:
Exceling at translating complex scientific concepts into clear and actionable insights for diverse audiences. Whether presenting to researchers, collaborating with executive leadership, or guiding customers through technology decisions, she communicates with clarity and confidence. Her relationship-focused communication style enables her to build strong partnerships and align stakeholders around shared goals.
